RNU6-928P

Across TCGA pan-cancer cohorts, RNU6-928P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RNU6-928P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU6-928P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-928P expression acts as an unfavorable survival marker, although some lineages such as LAML and LGG show a favorable association.

KIRC, COAD, and TGCT are the cancer types where RNU6-928P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	All	0.704	0.826	<.001	116	view →
COAD	OS	Tertile	III,IV	0.482	0.794	.001	87	view →
TGCT	DFS	Tertile	II,III,IV	0.339	0.955	<.001	72	view →
BLCA	DFS	Tertile	III,IV	0.215	0.481	.016	36	view →
LUAD	DFS	Tertile	IV	0.406	0.753	.008	36	view →
ACC	DFS	Tertile	III,IV	0.053	0.471	.001	18	view →
LAML	DFS	Median	All	0.647	0.311	.003	12	view →
LGG	OS	Tertile	All	0.957	0.781	.035	3	view →
THCA	DFS	Tertile	All	0.772	0.946	.037	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RNU6-928P–KIRC (DFS)

Open the KIRC breakdown →